Quince Therapeutics Inc. (QNCX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Quince Therapeutics Inc.

NASDAQ: QNCX · Real-Time Price · USD
1.65
0.01 (0.61%)
At close: Oct 03, 2025, 3:59 PM
1.68
1.82%
After-hours: Oct 03, 2025, 06:30 PM EDT

Quince Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.21M 20.75M 44.58M 69.72M
Short-Term Investments
34.57M 54.31M 45.6M 37.08M
Long-Term Investments
78K 78K 3.58M 19.93M
Other Long-Term Assets
9.51M 8.47M -1.03M 194K
Receivables
882K 993K 1M 1.13M
Inventory
n/a n/a n/a n/a
Other Current Assets
84K 81K 276K 367K
Total Current Assets
44.04M 77.44M 93.75M 111.67M
Property-Plant & Equipment
813K 619K 684K 1.43M
Goodwill & Intangibles
60.05M 81.3M 5.9M n/a
Total Long-Term Assets
70.44M 90.46M 10.16M 21.55M
Total Assets
114.48M 167.9M 103.91M 133.23M
Account Payables
2.9M 2.03M 570K 4.91M
Deferred Revenue
n/a n/a n/a 8.39M
Short-Term Debt
96K 64K 453K 741K
Other Current Liabilities
212K 5.07M 463K -8.95M
Total Current Liabilities
7.28M 9.57M 3.07M 14.22M
Long-Term Debt
14.32M 13.43M n/a n/a
Other Long-Term Liabilities
57.38M 54.19M n/a n/a
Total Long-Term Liabilities
77.05M 73.24M 248K 420K
Total Liabilities
84.33M 82.82M 3.32M 14.64M
Total Debt
14.81M 13.81M 453K 1.16M
Book Value
30.15M 85.08M 100.59M 118.59M
Book Value Per Share
0.70 2.28 3.00 3.99
Common Stock
44K 43K 36K 30K
Retained Earnings
-376.47M -319.64M -288.26M -236.6M
Comprehensive Income
-35K 3.05M -289K -79K
Shareholders Equity
30.15M 85.08M 100.59M 118.59M
Total Investments
34.65M 54.38M 49.18M 57.01M